Product Description
Mechanisms of Action: G-CSF
Novel Mechanism: No
Modality: Peptide/Protein
Route of Administration: Subcutaneous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Chile | Croatia | Czech | Denmark | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hungary | Iceland | Ireland | Israel | Italy | Korea | Latvia | Lithuania | Luxembourg | Mexico | Netherlands | New Zealand | Norway | Peru | Poland | Portugal | Romania | Russia | Singapore | Slovakia | Slovenia | Spain | Sweden | Taiwan | Turkey | United Arab Emirates | United Kingdom
Approved Indications: None
Known Adverse Events: None
Company: Teva
Company Location: PETACH TIKVA L3 49131
Company CEO: Kåre Schultz
Additional Commercial Interests: None
Clinical Description

Countries in Clinic: New Zealand, United States
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Hepatitis B, Chronic|Intestinal Diseases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
---|---|---|---|---|---|---|---|
2006-7041-83/hah | P2 |
Not yet recruiting |
Hepatitis B, Chronic|Intestinal Diseases |
None |
43% |
Recent News Events
Date |
Type |
Title |
---|---|---|
05/14/2024 |
PubMed |
Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study. |
04/30/2024 |
PubMed |
Dimethyl sulfoxide as a gas phase charge-reducing agent for the determination of PEGylated proteins' intact mass. |
03/29/2024 |
PubMed |
Severe Pseudomonas aeruginosa Pneumonia in a Breast Cancer Patient Despite Pegfilgrastim Administration. |
01/11/2023 |
News Article |
G-CSFPEG-G-CSF Market Set to Reach at USD 5,685.40 Million by 2030, Size, Share, Demand, Future Growth and Competitors Outlook |
03/11/2022 |
News Article |
Neutropenia Biologic Drug Treatment Global Market Report 2022 |
03/03/2022 |
News Article |
G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2022 |
12/08/2021 |
News Article |
Neutropenia Biologic Drug Treatment Global Market Research Report 2021 - ResearchAndMarkets.com |